AstraZeneca

OTC: AZNCF · Real-Time Price · USD
155.50
-0.25 (-0.16%)
At close: Aug 15, 2025, 3:42 PM
155.75
0.16%
After-hours: Aug 13, 2025, 08:00 PM EDT

AstraZeneca Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
8.69B 6.9B 2.5B -265M
Depreciation & Amortization
4.96B 5.05B 5.48B 6.53B
Stock-Based Compensation
n/a 579M 619M 615M
Other Working Capital
862M -7.23M -3.34M 7.59M
Other Non-Cash Items
-914.79M -2.49B -1.93B -2.32B
Deferred Income Tax
n/a n/a -619M -615M
Change in Working Capital
-874.33M 300M 3.76B 2.02B
Operating Cash Flow
11.86B 10.35B 9.81B 5.96B
Capital Expenditures
-4.59B -3.78B -2.57B -2.2B
Cash Acquisitions
-3.93B -1.1B -1.06B -9.43B
Purchase of Investments
-96M -136M -159M -184M
Sales Maturities Of Investments
118.47M 132.11M 42M 105M
Other Investing Acitivies
-2.15B -1.6B 789M 654M
Investing Cash Flow
-7.98B -4.06B -2.96B -11.06B
Debt Repayment
1.81B -965M -1.51B 7.76B
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-4.63B -4.48B -4.28B -3.79B
Other Financial Acitivies
-1.13B -1.15B -944M -254.09M
Financial Cash Flow
-4B -6.57B -6.82B 3.65B
Net Cash Flow
-208M -346M -55M -1.51B
Free Cash Flow
7.28B 6.57B 7.24B 3.76B